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Introduction
Triploidy is a genetic disorder with three complete
haploid sets of chromosomes (69,XXX, 69,XXY, or
69,XYY). The extra haploid set of chromosomes may
be of paternal or maternal origin. Based on the phe-
notypes and parental origins of the extra haploid
set, triploid fetuses can be classified into two types:
diandric triploidy (type I) and digynic triploidy
(type II) [1,2]. The prevalence of triploid pregnancy
is approximately 1% of all human conceptions [3],
around 0.03% at 10–14 weeks of gestation [4], and
0.002% at 16–20 weeks of gestation [5]. Most trip-
loid conceptions end as spontaneous abortions in
early development. Very few triploid fetuses survive
to term [6]; the survivors are profoundly growth-
restricted and severely malformed and often die
within a few days after delivery.
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Fetuses with triploidy tend to die in early pregnancy, with few surviving to term. The sur-
vivors are profoundly growth-restricted and severely malformed and often die within a few
days of birth. Triploid fetuses clinically exhibit a wide spectrum of sonographically detectable
abnormalities. This article provides an overview of the common sonographic abnormalities of
triploid fetuses, including extra-fetal anomalies (such as an enlarged and cystic placenta,
oligohydramnios, and enlarged maternal ovaries with multicystic change) and fetal structural
anomalies (such as intrauterine growth restriction, increased fetal nuchal translucency thick-
ness, central nervous system anomalies, facial anomalies, genitourinary anomalies, cardiac
anomalies, gastrointestinal anomalies, and limb defects). Recognition of these different
sonographic features is useful in predicting the parental origin of triploidy. Clinically, several
diseases that have a phenotypic overlap with triploidy include complete mole with a coexis-
tent fetus in dizygotic twins, a normal fetus with placental mesenchymal dysplasia, trisomies
13 and 18, and Neu–Laxova syndrome. Because of the serious and lethal birth defects, pre-
natal ultrasound is a valuable tool in detecting the variety of extra-fetal and fetal structural
malformations associated with triploidy throughout gestation; prenatal recognition of these
sonographic features is of great help in early karyotypic confirmation, enabling appropriate
genetic counseling and reasonable obstetric treatment.
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Clinically, triploid fetuses may manifest broad
spectrums of phenotypic features, including placen-
tal changes, intrauterine growth restriction (IUGR),
increased fetal nuchal translucency thickness (NT),
and anatomic defects of the brain, face, heart, and
limbs [7,8]. No uniform sonographic features are
reported in association with triploidy in previous
studies of limited numbers of triploid fetuses, and
the absence of prenatal fetal anomalies cannot
exclude a diagnosis of triploidy [9,10]. A recent study
of second-trimester sonographic detection of 70 trip-
loid cases found that fetal anatomic defects could
be identified in 65 cases (92.9%) [2]. Due to the
significantly increased death rate of triploid fetuses
prenatally and neonatally, and the risk of maternal
complications in association with triploidy, it is
important to make an accurate diagnosis as early
as possible during pregnancy. The aim of this article
is to review the common sonographic characteris-
tics for early prenatal detection of triploidy. Prenatal
recognition of these sonographic features is of great
help in early karyotypic confirmation and in predict-
ing parental origin, and enables appropriate genetic
counseling and obstetric treatment. The differential
diagnosis of fetuses with triploidy is also discussed
(Table).
Prenatal Sonographic Features
Sonographic findings associated with triploid fetuses
can be classified as extra-fetal anomalies such as an
enlarged and cystic placenta, oligohydramnios, and
enlarged maternal ovaries with multicystic change,
and as fetal structural anomalies that include IUGR,
increased fetal NT, central nervous system (CNS)
anomalies, facial anomalies, genitourinary anomalies,
cardiac anomalies, gastrointestinal anomalies, and
limb defects.
Extra-fetal anomalies
Placenta
Abnormal placentas with varying sonographic ap-
pearances, ranging from an enlarged size with multi-
cystic components (grapelike vesicles in the placenta)
to partial moles, were found in 28.6–55% (11/20)
of triploid pregnancies [2,4,11]. Triploid pregnancies
associated with abnormal placentas with large and
hydropic change, consistent with partial moles, are
often seen in diandric triploidy. In contrast, digynic
triploid fetuses are often seen with normal-looking
but small placentas.
Amniotic fluid
Approximately 40–60% of triploid fetuses were seen
in association with moderate to profound oligohy-
dramnios; polyhydramnios was rarely reported, with
a frequency of only 5% in triploid fetuses [2,8,9,
11,12]. Renal dysplasia or decreased renal blood
flow as a consequence of IUGR was considered to
be the cause of oligohydramnios [9,11].
Maternal ovaries
The presence of enlarged maternal ovaries with mul-
tiple cysts, also termed theca-lutein cysts, is highly
associated with a complete molar pregnancy, hor-
monal stimulation for artificial reproductive tech-
niques, and multiple gestations. Despite its rarity, the
appearance of theca-lutein cysts in early pregnancy
can be seen in association with triploid gestations
[11,13], with an incidence of approximately 10% of
triploid pregnancies [2,10]. The presence of ovarian
theca-lutein cysts supposedly relates to the abnormal
elevation of maternal serum β-human chorionic go-
nadotrophin (β-HCG) levels produced by trophoblas-
tic hyperplasia; high circulating serum levels of this
protein are common in triploid gestations [4,14].
Fetal structural anomalies
Intrauterine growth restriction
IUGR is defined as predicted fetal weight below the
10th percentile for gestational age. It is the most dis-
tinguishable sonographic feature of fetal triploidy,
with a reported incidence of 55–100% in different
series, and with an average growth lag (difference
from that expected by dates) of 2–6 weeks [2,4,
8–12]. Symmetrical IUGR is more common in fetuses
with diandric triploidy, and asymmetrical IUGR is
often seen in fetuses with digynic triploidy. Asymmet-
rical growth restriction is observed in triploid fetuses,
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with the trunk being more severely compromised
than the head at 11–13+6 weeks of gestation [15].
The occurrence of IUGR is potentially evident as
early as 10 weeks’ gestation [8,16,17]. Pircon et al
suggested that IUGR could be the result of either
first-trimester IUGR with subsequent normal growth
or delayed ovulation and/or fertilization [10].
Increased nuchal translucency thickness
Increased fetal NT, characterized as a nonspecific
and transient fetal anomaly, has been significantly
associated with chromosomal abnormalities includ-
ing triploidy. Early detection of triploidy leads to the
identification of more than 65% of triploid fetuses
with increased fetal NT [4]. A recent review found
that increased NT is commonly seen in fetuses with
diandric triploidy and that normal NT is commonly
detected in fetuses with digynic triploidy [18].
Central nervous system anomalies
CNS anomalies are the second most common sono-
graphic features following IUGR, with a reported
frequency of approximately 50% of triploid cases
[2,9–12]. The reported associated CNS anomalies
include ventriculomegaly, Dandy–Walker malfor-
mation or variant, agenesis of the corpus callosum,
holoprosencephaly (HPE), interhemispheric cyst,
posterior fossa cyst, encephalocele, neural tube
defects, and others. Second-trimester sonographic
diagnosis of 70 triploid fetuses identified 24 cases
with ventriculomegaly, five with spina bifida, five
with Dandy–Walker malformation, and two with
HPE [2]. First-trimester sonographic diagnosis of 18
triploid fetuses identified four cases with HPE (22.2%,
4/18) and one case with posterior fossa cyst (1/18)
[4]. In a prenatal sonographic study of 20 triploid
fetuses, CNS anomalies were observed in 45% (9/20)
of cases, including four cases with open neural tube
defects, two with isolated ventriculomegaly, one with
corpus callosum agenesis and an interhemispheric
cyst, one with encephalocele, and one with micro-
cephaly [11]. Prenatal sonographic findings of
CNS anomalies in 13 triploid fetuses included six
cases with bilateral cerebral ventriculomegaly
(6/13) and four with Dandy–Walker malformation
or Dandy–Walker variant (4/13), which is sug-
gested to be an additional sonographic marker for
fetal triploidy [19].
Facial anomalies
Facial anomalies seen in prenatal triploids include
microcephaly or relative macrocephaly, low-set ears,
micrognathia, hypertelorism, facial clefts, cyclopia,
proboscis, single nostril, and others [11,20,21].
Second-trimester sonographic diagnosis of 70 trip-
loid fetuses identified 17 cases with micrognathia
and one case with cleft lip and palate [2]. When
ocular anomalies or midline facial defects are seen
in association with HPE, chromosomal aneuploidy
including triploidy should be strongly suspected.
Genitourinary anomalies
Genitourinary anomalies associated with triploidy
include renal cystic dysplasia, hydronephrosis, am-
biguous external genitalia, hypospadias, and others.
Second-trimester sonographic diagnosis of 70 trip-
loid fetuses identified eight cases (11.4%) with renal
malformations [2]. Genital maldevelopment was
detected in male fetuses with triploidy [22]. Prenatal
sonographic detection of 20 triploid fetuses identi-
fied 3 cases with urinary anomalies of cystic kidneys
and dilated renal pelvis. Postmortem examination
of these 20 triploid fetuses revealed additional geni-
tourinary anomalies, including renal agenesis, renal
hypoplasia, renal cystic dysplasia, horseshoe kidney,
and bicornuate uterus; these abnormalities may have
been missed because of poor sonographic scans [11].
Cardiac anomalies
Postmortem examination of cardiac anomalies 
in triploid fetuses revealed ventricular septal defects,
atrial septal defects, pulmonary stenosis, aberrant
right subclavian artery, truncus arteriosus, and 
others [11]. Prenatal sonographic detection of car-
diac anomalies differs significantly among studies.
Second-trimester sonographic diagnosis of 70 trip-
loid fetuses identified 22 cases (31.4%) with cardiac
anomalies [2]. However, only one case with cardiac
anomalies was detected prenatally from 20 cases of
triploidy [11].
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Gastrointestinal anomalies or abdominal 
wall defects
The gastrointestinal defects associated with triploidy
include omphalocele, gastroschisis, collapsed stom-
ach, congenital diaphragmatic hernia (CDH), duo-
denal obstruction, and others. The occurrence of
omphalocele could be suggestive of triploidy [22],
while 10–18% of triploid fetuses had associated
omphalocele or gastroschisis [23]. First-trimester
sonographic diagnosis of 18 triploid fetuses identi-
fied three cases with exomphalos (16.7%, 3/18) [4].
Another first-trimester study revealed fetal exompha-
los in 12.5% of fetuses with triploidy [24]. Second-
trimester sonographic diagnosis of 70 triploid fetuses
identified four cases with omphalocele, five with
collapsed stomach, and one with CDH [2]. CDH was
prenatally diagnosed in a digynic triploid fetus [25].
Prenatal sonographic detection of duodenal obstruc-
tion as a “double bubble” sign was associated with
a triploid fetus [26].
Limb defects
Postmortem examination of limb defects in trip-
loid fetuses revealed syndactyly, clinodactyly, simian
crease, flexion deformity, bowed legs, talipes equi-
novarus, hitchhiker’s toe, wide gap between toes,
and prominent heels [11]. In 65 triploid fetuses with
anatomic defects, malformed hands were prenatally
detected in 34 cases (52.3%, 34/65), of which syn-
dactyly of the third and fourth digits was the most
common, and 5 cases had talipes equinovarus (7.7%,
5/65) [2]. However, few limb anomalies are recog-
nized by prenatal sonography, with the possible
causes of oligohydramnios, unfavorable fetal postures,
suboptimal visualization of fetuses, maternal obesity,
and the earlier sonographic scanning.
Molecular Analysis and Clinical
Manifestations
Based on molecular polymorphism studies of the
parental extra haploid set in triploidy, the majority
of triploid conceptions are diandric, resulting from
fertilization of a normal ovum with either a diploid
sperm or two sperms. Less than 20% of triploids
are digynic, resulting from a double maternal con-
tribution with a meiosis I or II error of the ovum
[27,28]. The triploid karyotype may be 69,XXX,
69,XXY, or 69,XYY from a supernumerary paternal
haploid set and 69,XXX, or 69,XXY from an extra
maternal haploid set. The incidence of 69,XYY is
extremely low; very few 69,XYY conceptions sur-
vive beyond the second month of pregnancy [3].
The maternal contribution is reported to be essen-
tial for normal embryonal growth and develop-
ment; importantly, the paternal contribution controls
the growth of extraembryonic tissue such as the
placenta [29,30].
Clinically, two distinct fetal phenotypes and dif-
ferent levels of first-trimester or second-trimester
maternal serum markers have been delineated in
association with triploidy [1,2,31]. Fetuses of diandric
triploidy (type I) are characterized by a relatively well-
grown fetus with or without microcephaly, extremely
high levels of free β-HCG and α-fetoprotein (α-FP),
increased fetal NT, and a large cystic placenta with
partial molar changes that may affect the mother
with varying degrees of preeclampsia during preg-
nancy or persistent trophoblastic disease after deliv-
ery [18,32,33]. Fetuses with digynic triploidy (type II)
present with severe asymmetrical IUGR, relative
macrocephaly, low levels of pregnancy-associated
plasma protein-A and free β-HCG, normal fetal NT,
and an apparently normal but small placenta.
Despite these differences, there is still phenotypic
overlap between the two types [2,18].
Differential Diagnosis
Prenatal sonographic features of triploid partial molar
pregnancy include fetal and placental changes. Simi-
lar sonographic findings may be seen in several
types of pregnancy, including complete mole with a
coexistent fetus (CMCF) in dizygotic twins, a nor-
mal fetus with placental mesenchymal dysplasia
(PMD), trisomies 13 and 18, and Neu–Laxova syn-
drome (NLS). In addition, a triploid fetus may be
mistaken for a normal fetus with growth restriction
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and a small placenta with poor function resulting
from constitution or intrauterine infection. There-
fore, cytogenetic investigation is necessary for a
definite diagnosis of fetal triploidy.
Complete mole with a coexistent fetus in
dizygotic twins
The incidence of dizygotic twins with CMCF has
been reported as 0.001–0.0046% pregnancies
[34]. It has been reported to be associated with
potential life-threatening maternal complications
with pregnancy continuation, such as preeclampsia,
hyperthyroidism, pulmonary edema, and gesta-
tional trophoblastic disease [35]. To distinguish 
a triploid partial mole from CMCF is difficult on 
histologic examination alone [36]. Additional
genetic analyses of ploidy and DNA polymorphic
markers can improve the diagnostic accuracy in
molar pregnancy [37–40]. Genetic analysis of com-
plete molar tissue often shows a diploid karyotype
of only paternal origin, despite a rare occurrence of
biparental complete moles observed as a familial
case; most partial moles show a triploid karyotype
[41,42].
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Table. Prenatal sonographic features of triploidy and differential diagnosis
Prenatal sonographic features
Extra-fetal anomalies
Enlarged placentas with multicystic spaces to partial moles or small placenta
Oligohydramnios
Theca-lutein cysts in maternal ovaries
Fetal structural anomalies
Intrauterine growth restriction
Increased fetal nuchal translucency thickness
Central nervous system anomalies
Ventriculomegaly, Dandy–Walker malformation, agenesis of corpus callosum, holoprosencephaly,
interhemispheric cyst, posterior fossa cyst, encephalocele, neural tube defects, and others
Facial anomalies
Microcephaly or relative macrocephaly, low-set ears, micrognathia, hypertelorism, facial clefts, 
cyclopia, proboscis, single nostril, and others
Genitourinary anomalies
Renal cystic dysplasia, hydronephrosis, ambiguous external genitalia, hypospadias, and others
Cardiac anomalies
Ventricular septal defects, atrial septal defects, pulmonary stenosis, and others
Gastrointestinal anomalies or abdominal wall defects
Omphalocele, gastroschisis, collapsed stomach, congenital diaphragmatic hernia, duodenal obstruction, 
and others
Limb defects
Syndactyly (especially the third and fourth digits), flexion deformity, talipes equinovarus, hitchhiker’s toe, 
and others
Differential diagnosis of a triploid partial molar pregnancy
Complete mole with a coexistent fetus in dizygotic twins
A normal fetus with placental mesenchymal dysplasia
Trisomies 13 and 18
Neu–Laxova syndrome
Normal fetus with PMD
PMD is a rare condition of pregnancy characterized
by placentomegaly and multicystic change and
presents with sonographic features of molar change.
It is also called pseudo-partial mole [43,44]. The
condition is often associated with a karyotypically
and phenotypically normal fetus and rarely with a
growth-restricted fetus or a fetus with features of
Beckwith–Wiedemann syndrome (BWS) [45]. Poly-
hydramnios may be present if the fetus has a swal-
lowing difficulty as part of BWS. The histologic
hallmarks include enlarged stem villi containing
loose, moderate connective tissue with focal cistern-
like formation and the absence of abnormal tro-
phoblastic proliferation and stromal trophoblastic
inclusions. Normal or slightly increased maternal
serum β-HCG and α-FP levels during pregnancy
may be seen in association with PMD [46,47]. Most
cases are asymptomatic throughout gestation;
hence, a detailed sonographic scan of fetal mor-
phology for early recognition of fetal anomalies
and karyotypic confirmation is important to avoid
unnecessary termination of pregnancy in cases
associated with a normal fetus.
Trisomies 13 and 18
Many similar fetal structural anomalies can be detec-
ted in fetuses with triploidy, trisomy 13, and trisomy
18, such as increased NT, IUGR, CNS anomalies,
facial anomalies, cardiac anomalies, genitourinary
anomalies, and gastrointestinal defects. Trisomy
18 is often associated with polyhydramnios in late
gestation, but triploidy is often present with oligo-
hydramnios. Despite that more than 90% of par-
tial moles are associated with diandric triploidy,
placental molar presentation with multiple fetal
abnormalities can be observed in cases of trisomy
13 [48]; therefore, a definite diagnosis should be
achieved by fetal karyotyping.
NLS (OMIM 256520)
NLS is an autosomal recessive disorder character-
ized by a lethal dysplasia with placental anomalies,
severe IUGR, fetal edema, ectodermal dysplasia,
and the cerebroarthrodigital complex with severe
CNS anomalies [49]. The first case was reported 
in 1971 [50]; prenatal detection of the syndrome
during the second trimester of gestation is possible
[51]. Fetuses with NLS and triploidy may have sim-
ilar structural anomalies, but the excessive depo-
sition of subcutaneous tissue with edema is a
hallmark feature of NLS on a sonographic scan. In
addition, a history of parental consanguinity or
prior affected child has been documented in cases
of NLS.
Summary
With the advent of ultrasound equipment, the use
of prenatal ultrasound has greatly improved the
detection of triploid fetuses in obstetric practice. The
increased understanding of different sonographic
features is helpful in detecting triploid fetuses
throughout gestation. Although several diseases
have phenotypic overlaps with triploidy, major
sonographic features that alert the physician to the
possible diagnosis of triploidy are extra-fetal anom-
alies such as an enlarged and cystic placenta, oligo-
hydramnios, and enlarged maternal ovaries with
multicystic change, and fetal structural anomalies
such as IUGR, increased fetal NT, CNS anomalies,
facial anomalies, genitourinary anomalies, cardiac
anomalies, gastrointestinal anomalies, and limb
defects. These sonographic features are also useful in
predicting the parental origin of triploidy. Clinically,
several diseases may have phenotypic overlaps with
triploidy; therefore, early sonographic identifica-
tion of these anomalies in triploid fetuses is impor-
tant in providing earlier karyotypic confirmation
and enabling more reasonable management for
pregnant women.
References
1. McFadden DE, Kalousek DK. Two different pheno-
types of fetuses with chromosomal triploidy: corre-
lation with parental origin of the extra haploid set.
Am J Med Genet 1991;38:535–8.
C.P. Chen, S.C. Chien, H.H. Lin
180 J Med Ultrasound 2007 • Vol 15 • No 3
2. Jauniaux E, Brown R, Rodeck C, et al. Prenatal diag-
nosis of triploidy during the second trimester of preg-
nancy. Obstet Gynecol 1996;88:983–9.
3. Doshi N, Surti U, Szulman AE. Morphologic anom-
alies in triploid liveborn fetuses. Hum Pathol 1983;14:
716–23.
4. Jauniaux E, Brown R, Snijders RJ, et al. Early prenatal
diagnosis of triploidy. Am J Obstet Gynecol 1997;176:
550–4.
5. Ferguson-Smith MA, Yates JR. Maternal age specific
rates for chromosome aberrations and factors influ-
encing them: report of a collaborative european study
on 52 965 amniocenteses. Prenat Diagn 1984;4 (Spec
No):5–44.
6. Jacobs PA, Szulman AE, Funkhouser J, et al. Human
triploidy: relationship between parental origin of the
additional haploid complement and development of
partial hydatidiform mole. Ann Hum Genet 1982;46:
223–31.
7. Szulman AE, Philippe E, Boue JG, et al. Human
triploidy: association with partial hydatidiform moles
and nonmolar conceptuses. Hum Pathol 1981;12:
1016–21.
8. Crane JP, Beaver HA, Cheung SW. Antenatal ultra-
sound findings in fetal triploidy syndrome. J Ultrasound
Med 1985;4:519–24.
9. Lockwood C, Scioscia A, Stiller R, et al. Sonographic
features of the triploid fetus. Am J Obstet Gynecol
1987;157:285–7.
10. Pircon RA, Porto M, Towers CV, et al. Ultrasound
findings in pregnancies complicated by fetal triploidy.
J Ultrasound Med 1989;8:507–11.
11. Mittal TK, Vujanic GM, Morrissey BM, et al.
Triploidy: antenatal sonographic features with post-
mortem correlation. Prenat Diagn 1998;18:1253–62.
12. Edwards MT, Smith WL, Hanson J, et al. Prenatal
sonographic diagnosis of triploidy. J Ultrasound Med
1986;5:279–81.
13. Frates MC, Feinberg BB. Early prenatal sonographic
diagnosis of twin triploid gestation presenting with
fetal hydrops and theca-lutein ovarian cysts. J Clin
Ultrasound 2000;28:137–41.
14. Schmidt D, Shaffer LG, McCaskill C, et al. Very low
maternal serum chorionic gonadotropin levels in
association with fetal triploidy. Am J Obstet Gynecol
1994;170:77–80.
15. Falcon O, Cavoretto P, Peralta CF, et al. Fetal head-
to-trunk volume ratio in chromosomally abnormal
fetuses at 11 + 0 to 13 + 6 weeks of gestation. Ultra-
sound Obstet Gynecol 2005;26:755–60.
16. Benacerraf BR. Intrauterine growth retardation in the
first trimester associated with triploidy. J Ultrasound
Med 1988;7:153–4.
17. Kuhn P, Brizot ML, Pandya PP, et al. Crown-rump
length in chromosomally abnormal fetuses at 10 to 13
weeks’ gestation. Am J Obstet Gynecol 1995;172:32–5.
18. Spencer K. Aneuploidy screening in the first trimester.
Am J Med Genet C Semin Med Genet 2007;145:18–32.
19. Blaicher W, Ulm B, Ulm MR, et al. Dandy-Walker
malformation as sonographic marker for fetal
triploidy. Ultraschall Med 2002;23:129–33.
20. Hsu TY, Chang SY, Ou CY, et al. First trimester diagno-
sis of holoprosencephaly and cyclopia with triploidy
by transvaginal three-dimensional ultrasonography.
Eur J Obstet Gynecol Reprod Biol 2001;96:235–7.
21. Chen CP, Hsu HC, Chern SR, et al. Second-trimester
diagnosis of digynic triploidy in a case of anhydram-
nios and fetal cyclopia by ultrasound-guided trans-
abdominal chorionic villus sampling. Ultrasound Obstet
Gynecol 2002;20:415–6.
22. Wertelecki W, Graham JM Jr, Sergovich FR. The clini-
cal syndrome of triploidy. Obstet Gynecol 1976;47:
69–76.
23. Blackburn WR, Miller WP, Superneau DW, et al.
Comparative studies of infants with mosaic and com-
plete triploidy: an analysis of 55 cases. Birth Defects
Orig Artic Ser 1982;18:251–74.
24. Snijders RJ, Sebire NJ, Souka A, et al. Fetal exompha-
los and chromosomal defects: relationship to mater-
nal age and gestation. Ultrasound Obstet Gynecol 1995;6:
250–5.
25. Bianca S, Ettore G, Gullotta G, et al. Prenatal diagno-
sis of congenital diaphragmatic hernia in a McFadden
Kalousek type 2 triploid fetus. Fetal Diagn Ther 2004;
19:49–51.
26. Lawrence MJ, Ford WD, Furness ME, et al. Congenital
duodenal obstruction: early antenatal ultrasound diag-
nosis. Pediatr Surg Int 2000;16:342–5.
27. Lindor NM, Ney JA, Gaffey TA, et al. A genetic review
of complete and partial hydatidiform moles and
nonmolar triploidy. Mayo Clin Proc 1992;67:791–9.
28. Szulman AE, Surti U. The syndromes of hydatidiform
mole. I. Cytogenetic and morphologic correlations.
Am J Obstet Gynecol 1978;131:665–71.
29. Daniel A, Wu Z, Bennetts B, et al. Karyotype, pheno-
type and parental origin in 19 cases of triploidy.
Prenat Diagn 2001;21:1034–48.
30. McFadden DE, Hulait G, Lockitch G, et al. Maternal
serum screening in triploidy. Prenat Diagn 2002;22:
1113–4.
Prenatal Sonography of Triploidy
181J Med Ultrasound 2007 • Vol 15 • No 3
31. Yaron Y, Ochshorn Y, Tsabari S, et al. First-trimester
nuchal translucency and maternal serum free beta-
hCG and PAPP-A can detect triploidy and determine
the parental origin. Prenat Diagn 2004;24:445–50.
32. Nugent CE, Punch MR, Barr M Jr, et al. Persistence of
partial molar placenta and severe preeclampsia after
selective termination in a twin pregnancy. Obstet
Gynecol 1996;87:829–31.
33. Goldstein DP, Berkowitz RS. Current management of
complete and partial molar pregnancy. J Reprod Med
1994;39:139–46.
34. Vejerslev LO. Clinical management and diagnostic
possibilities in hydatidiform mole with coexistent
fetus. Obstet Gynecol Surv 1991;46:577–88.
35. Matsui H, Sekiya S, Hando T, et al. Hydatidiform mole
coexistent with a twin live fetus: a national collabora-
tive study in Japan. Hum Reprod 2000;15:608–11.
36. Gschwendtner A, Neher A, Kreczy A, et al. DNA
ploidy determination of early molar pregnancies by
image analysis: comparison to histologic classifica-
tion. Arch Pathol Lab Med 1998;122:1000–4.
37. Baergen RN, Kelly T, McGinniss MJ, et al. Complete
hydatidiform mole with a coexistent embryo. Hum
Pathol 1996;27:731–4.
38. Harada I, Tsutsumi O, Takai Y, et al. DNA polymor-
phism analysis of a case of complete hydatidiform
mole coexisting with a fetus. Hum Reprod 1997;12:
2563–6.
39. Lage JM, Mark SD, Roberts DJ, et al. A flow cytometric
study of 137 fresh hydropic placentas: correlation
between types of hydatidiform moles and nuclear
DNA ploidy. Obstet Gynecol 1992;79:403–10.
40. Osada H, Iitsuka Y, Matsui H, et al. A complete hyda-
tidiform mole coexisting with a normal fetus was con-
firmed by variable number tandem repeat (VNTR)
polymorphism analysis using polymerase chain reac-
tion. Gynecol Oncol 1995;56:90–3.
41. Fisher RA, Paradinas FJ, Soteriou BA, et al. Diploid
hydatidiform moles with fetal red blood cells in
molar villi. 2–Genetics. J Pathol 1997;181:189–95.
42. Paradinas FJ, Fisher RA, Browne P, et al. Diploid hyda-
tidiform moles with fetal red blood cells in molar villi.
1–Pathology, incidence, and prognosis. J Pathol 1997;
181:183–8.
43. Moscoso G, Jauniaux E, Hustin J. Placental vascular
anomaly with diffuse mesenchymal stem villous hyper-
plasia. A new clinico-pathological entity? Pathol Res
Pract 1991;187:324–8.
44. Sander CM. Angiomatous malformation of placental
chorionic stem vessels and pseudo-partial molar pla-
centas: report of five cases. Pediatr Pathol 1993;13:
621–33.
45. Parveen Z, Tongson-Ignacio JE, Fraser CR, et al.
Placental mesenchymal dysplasia. Arch Pathol Lab Med
2007;131:131–7.
46. Paradinas FJ, Sebire NJ, Fisher RA, et al. Pseudo-partial
moles: placental stem vessel hydrops and the associ-
ation with Beckwith-Wiedemann syndrome and com-
plete moles. Histopathology 2001;39:447–54.
47. Cohen MC, Roper EC, Sebire NJ, et al. Placental mes-
enchymal dysplasia associated with fetal aneuploidy.
Prenat Diagn 2005;25:187–92.
48. Has R, Ibrahimoglu L, Ergene H, et al. Partial molar
appearance of the placenta in trisomy 13. Fetal Diagn
Ther 2002;17:205–8.
49. Scott CI, Louro JM, Laurence KM, et al. Comments
on the Neu-Laxova syndrome and CAD complex. Am
J Med Genet 1981;9:165–75.
50. Neu RL, Kajii T, Gardner LI, et al. A lethal syndrome
of microcephaly with multiple congenital anomalies
in three siblings. Pediatrics 1971;47:610–2.
51. Martin A, Eguiluz I, Barber MA, et al. A rare cause of
polyhydramnios: Neu-Laxova syndrome. J Matern Fetal
Neonatal Med 2006;19:439–42.
C.P. Chen, S.C. Chien, H.H. Lin
182 J Med Ultrasound 2007 • Vol 15 • No 3
